According to the latest report by IMARC Group, “Global Herpes Simplex Virus Treatment Market Size, Share, Growth, Industry Trends, Opportunity and Forecast 2023-2028“, the global herpes simplex virus treatment market size reached US$ 2.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.4 Billion by 2028, exhibiting a growth rate (CAGR) of 5.2% during 2023-2028.
Herpes simplex virus (HSV) refers to a contagious infection that spreads through bodily fluids like saliva, semen, and vaginal secretions and causes painful blisters or ulcers. Its diagnosis generally involves physical examinations, fluid sampling, and blood tests. Currently, antiviral medications, including famciclovir, acyclovir, and valacyclovir, are the most effective HSV treatment options available for patients across the globe. They can be administered orally or intravenously (IV) to help alleviate symptoms, reduce outbreak frequency and severity, and prevent virus transmission.
Request Free Sample Report: https://www.imarcgroup.com/herpes-simplex-virus-treatment-market/requestsample
Market Trends:
The global herpes simplex virus treatment market is primarily driven by the rising prevalence of chronic diseases. Moreover, neonatal herpes is a severe condition that can cause lasting neurological damage or even death in infants. In line with this, the inflating birth rates across the globe are positively influencing the market growth. Additionally, the rising reactivation rates of HSV infection in patients undergoing bone marrow and solid-organ transplants and the increasing number of transplants have catalyzed market growth.
Furthermore, the introduction of antiviral creams or ointments that can provide relief from the burning, itching, or tingling sensations of HSV, enhance the quality of life of patients, and prevent the spread of the virus is contributing to the market growth. Other factors, including ongoing research and development (R&D) activities, the rising prevalence of HSV, and the launch of new drugs, are also anticipated to drive the market further.
Click here to view detailed information with table of content: https://www.imarcgroup.com/herpes-simplex-virus-treatment-market
Global Herpes Simplex Virus Treatment Market 2023-2028 Analysis and Segmentation:
Competitive Landscape:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Herpes Simplex Virus Treatment Companies:
Avet Pharmaceuticals Inc., Carlsbad Tech, EPI Health LLC, F. Hoffmann-La Roche Ltd, Fresenius SE & Co. KGaA, Agenus Inc., Apotex Inc., GlaxoSmithKline plc, Glenmark Pharmaceuticals Limited, Merck & Co. Inc., Novartis AG, Sanofi S.A., Teva Pharmaceutical Industries Ltd. and Viatris Inc.
The report has segmented the market on the basis of type, drug type, route of administration, distribution channel and region.
Breakup by Type:
- Herpes Simples Virus-1 Infection
- Herpes Simplex Virus-2 Infection
- Others
Breakup by Drug Type:
- Acyclovir
- Valacyclovir
- Famciclovir
- Others
Breakup by Route of Administration:
- Oral
- Injectable
- Topical
Breakup by Distribution Channel:
- Hospital Pharmacy
- Drug Stores
- Retail Stores
- Online Pharmacy
Breakup by Region:
- North America
- Asia Pacific
- Europe
- Latin America
- Middle East and Africa
Ask an Analyst: https://www.imarcgroup.com/request?type=report&id=5257&flag=C
Key highlights of the report:
- Market Performance (2017-2022)
- Market Outlook (2023-2028)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
Email: sales@imarcgroup.com
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Website: https://www.imarcgroup.com/
Follow us on Twitter: @imarcglobal
Linkedin: https://www.linkedin.com/company/imarc-group